Xu Yuan
SEC insider (Form 3/4/5 filer). CIK 0001858214. Director at FATE THERAPEUTICS INC (FATE) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 12, 2026. Located in WALTHAM, MA.
Companies Xu Yuan has filed insider reports for
- FATE THERAPEUTICS INC (FATE): Director
- Xilio Therapeutics, Inc. (XLO): Director
- Akero Therapeutics, Inc. (AKRO): Director
Xu Yuan
CIK: 0001858214
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 12, 2026FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
87.9K shares- - Jun 11, 2026XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
5K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect9.4K shares- - Jun 11, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
31K shares- - Jun 3, 2025AKRO
Akero Therapeutics, Inc.
AwardDirect9.4K shares- - May 29, 2025FATE
FATE THERAPEUTICS INC
AwardDirectStock Option (Right to Buy)
55K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 12, 2026 |  FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 87,900 | - | - | Direct |
| Jun 11, 2026 |  XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 5,000 | - | - | Direct |
| Dec 9, 2025 |  AKRO Akero Therapeutics, Inc. | Disposition | 9,398 | - | - | Direct |
| Jun 11, 2025 | XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 31,000 | - | - | Direct |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | Award | 9,398 | - | - | Direct |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | Award Stock Option (Right to Buy) | 55,000 | - | - | Direct |
1-6 of 6 transactions